AAGH.US America Great Health
- Market cap
- USD 4.23M
- P/E
- -
- P/B
- 358,698.71x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is AAGH.US undervalued?
Graham numberThe Graham number of America Great Health cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
America Great Health fundamental analysis
No fundamental analysis for America Great Health yet.
America Great Health stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About America Great Health
America Great Health operates as a biotechnology company in the United States. The company focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and re-generational medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, Cali…
Full company profileAmerica Great Health financial statements
America Great Health annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 5.47K | 5.47K | 105K | 204K | 204K | 295K | 392K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 2.11K | 2.11K | -1.48M | 169K | 169K | 170K | 339K |
| Operating Income | -48.4K | -58.1K | -46.8K | -46.2K | -46.2K | -4.73M | -493K | -493K | -783K | -383K |
| EBITDA | -48.4K | -58.6K | -59.7K | - | -13.0K | -4.73M | -447K | -447K | -768K | -383K |
| Net Income | -919K | -59.4K | -65.0K | -51.9K | -51.9K | -4.87M | -761K | -761K | -1.22M | -721K |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 3.93K | 13.1K | 102.00 | 3.89K | 3.89K | 336K | 299K | 299K | 323K | 302K |
| Total Liabilities | 52.0K | 121K | 168K | 219K | 219K | 4.20M | 4.82M | 4.82M | 5.64M | 6.05M |
| Shareholders' Equity | -48.1K | -107K | -168K | -215K | -215K | -3.80M | -4.45M | -4.53M | -5.23M | -5.74M |
| Cash & Short-term Investments | 3.83K | 15.00 | 102.00 | 166.00 | 166.00 | 62.6K | 54.2K | 54.2K | 54.9K | 44.1K |
| Total Debt | 44.1K | 101K | - | - | 168K | 1.31M | 1.87M | 1.87M | 2.48M | 2.84M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -51.2K | -46.8K | -27.8K | -39.6K | -39.6K | -1.48M | -753K | -753K | -616K | -333K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 12.7K | 12.7K | 16.9K | 44.4K | 44.4K | 0.00 | 0.00 |
| Free Cash Flow | -51.2K | -46.8K | -27.8K | -39.6K | -39.6K | -1.50M | -797K | -797K | -616K | -333K |
| Ratios | ||||||||||
| ROA | -23,393.6% | -453.6% | -63,767.6% | -1,333.2% | -1,333.2% | -1,447.6% | -254.5% | -254.5% | -377.3% | -239.0% |
| Net Profit Margin | - | - | - | -948.4% | -948.4% | -4,650.0% | -372.7% | -372.7% | -414.2% | -184.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
America Great Health dividends
America Great Health has not paid dividends in the last 10 fiscal years.
Last stock split: 10:1 on Oct 10, 2012.
Who owns America Great Health
- Insiders 9.16%
- Institutions 0.00%
- Public & others 90.84%
- Shares outstanding 21.2B
- Free float 19.2B
America Great Health company profile
- Company name
- America Great Health
- Ticker
- AAGH.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Real Estate Management & Development
- Employees
- 5
- Fiscal year end
- June
- Address
- 1609 W. Valley Blvd., Alhambra, CA, United States, 91803
- Phone
- 888 988 1333
- Website
- aaghus.com
About America Great Health
America Great Health operates as a biotechnology company in the United States. The company focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and re-generational medicine and supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California.
America Great Health management
3- Mr. Mike Qingkun WangCEO, President, CFO, Secretary & Chairman of the Board · born 1955
- Mr. David LiuChief Operating Officer
- David TsaiChief Scientist